Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Volkow, N. D. Articles by Pappas, N. Search for Related Content PubMed Citation Articles by Volkow, N. D. Articles by Pappas, N.

Enhanced Sensitivity to Benzodiazepines in Active Cocaine-Abusing Subjects: A PET Study

OBJECTIVE: Because cocaine enhances dopamine brain activity and dopamine signals are transferred through -aminobutyric acid pathways, the authors hypothesized GABA-ergic disruption in cocaine-abusing subjects. This study tests this hypothesis. METHOD: GABA brain function was assessed indirectly by measuring the brain metabolic responses to lorazepam, a drug that facilitates GABA neurotransmission. Thirteen current cocaine-abusing subjects and 14 comparison subjects were scanned twice with positron emission tomography and [¹⁸F]fluorodeoxyglucose; the first scan was obtained after placebo administration and the second after lorazepam administration (30 µg/kg). RESULTS: Despite significantly higher plasma lorazepam concentrations in comparison subjects than in cocaine-abusing subjects, lorazepam-induced decrements in whole brain metabolism were significantly greater in cocaine-abusing (mean=21%, SD=13%) than in comparison (mean=13%, SD=7%) subjects. These differences were largest in striatum, thalamus, and parietal cortex. Lorazepam-induced sleepiness in cocaine-abusing subjects was intense and was significantly greater than in comparison subjects, and it was correlated with lorazepam-induced changes in thalamic metabolism. Whereas regional metabolic measures during placebo administration were significantly higher in cocaine-abusing subjects than in comparison subjects, the measures during lorazepam administration were equivalent for both groups. CONCLUSIONS: The enhanced sensitivity to lorazepam in cocaine-abusing subjects suggests disruption of GABA pathways that may reflect, in part, cocaine withdrawal. The intense sleepiness induced by lorazepam in some of the abusers, despite their significantly lower plasma concentrations, should alert clinicians of the potential toxicity from accentuated responses to sedative hypnotics in active cocaine-abusing subjects. (Am J Psychiatry 1998; 155:200–206)

This article has been cited by other articles:

				H. C. Urschel III, L. L. Hanselka, I. Gromov, L. White, and M. Baron Open-Label Study of a Proprietary Treatment Program Targeting Type A {gamma}-Aminobutyric Acid Receptor Dysregulation in Methamphetamine Dependence Mayo Clin. Proc., October 1, 2007; 82(10): 1170 - 1178. [Abstract] [Full Text] [PDF]

				G. Dom, B. Sabbe, W. Hulstijn, and W. van den Brink Substance use disorders and the orbitofrontal cortex: Systematic review of behavioural decision-making and neuroimaging studies The British Journal of Psychiatry, September 1, 2005; 187(3): 209 - 220. [Abstract] [Full Text] [PDF]

				W. G. van Gorp, J. N. Wilkins, C. H. Hinkin, L. H. Moore, J. Hull, M. D. Horner, and D. Plotkin Declarative and Procedural Memory Functioning in Abstinent Cocaine Abusers Arch Gen Psychiatry, January 1, 1999; 56(1): 85 - 89. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us